Tipranavir, or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) manufactured by Boehringer-Ingelheim under the trade name Aptivus. It is administered with ritonavir in combination therapy to treat HIV infection. Tipranavir has the ability to inhibit the replication of viruses that are resistant to other protease inhibitors and it recommended for patients who are resistant to other treatments. Resistance to tipranavir itself seems to require multiple mutations.
http://bioinformations.info/?p=460 Cheers, Julian Thomas http://bioisolutions.blogspot.com/ The day u belive u reached your fullest potential, is the day u haven't.- Nick Vujicic --~--~---------~--~----~------------~-------~--~----~ Dear Member, http://www.cbclickbank.com/biofriend/ Biofriend is now with great features. Like No email, catgorywise que & ans. rating and much more visit biofriend and We are sure, You will definitely like it. Ask your question Here ! http://www.cbclickbank.com/biofriend/ Get your Answers. Support Us to Help Others Biofriend India Team Please visit this link & send your friends too ========================================= " No email " visit http://www.cbclickbank.com/bioinformatics/giudence.htm -~----------~----~----~----~------~----~------~--~---
